Abstract:Precision or personalized medicine aims to determine an optimal therapy for each individual patient. In oncology techniques such as next generation sequencing, mRNA‐sequencing, ChIP‐sequencing, and mass spectrometry are used to perform a full molecular profiling for each patient. However, it is not always possible to determine a suitable treatment for an individual cancer based on molecular profiling, mostly due to the high level of tumor heterogeneity. In vitro drug sensitivity and resistance test (DSRT) can be performed on cancer cells or tissues obtained from a patient with a panel of anticancer compounds in order to experimentally define sensitivity and resistance of each individual cancer. In combination with molecular profiling, DSRT can provide a fuller picture about the nature of disease, allowing for finding more appropriate therapy for each individual patient. In this progress report, studies describing in vitro DSRTs on 2D and 3D cell models based on patient‐derived cells are reviewed and challenges and future steps needed for the adaptation of these systems in clinics are discussed. Precision medicine aims to determine an optimal therapy for each patient. In vitro drug sensitivity and resistance tests (DSRTs) are performed on patient cancer cells with anticancer drugs in order to define sensitivity and resistance of individual cancer. In this progress report, studies describing DSRT are reviewed and challenges and future steps needed for its adaptation in clinics are discussed.

Anticancer Drug Sensitivity Testing, A Historical Review And Future Perspectives

Personalized Cancer Therapy Using a Patient-Derived Tumor Tissue Xenograft Model: a Translational Field Worthy of Exploring Further?

Anticancer Drug Development, System Updating And Global Participations

Anticancer drug combinations : The next medical challenge

Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination – An effective strategy to improve clinical treatment

Drug Combination in Clinical Cancer Treatments

Finding New Tricks for Old Drugs: Tumoricidal Activity of Non-Traditional Antitumor Drugs

Building Consensus on the Application of Organoid-Based Drug Sensitivity Testing in Cancer Precision Medicine and Drug Development

Anticancer Drug Combinations, How Far We Can Go Through?

Natural Products in Cancer Therapy: Past, Present and Future

Historical Perspective and Current Trends in Anticancer Drug Development

Individualized Cancer Therapy, Future Approaches

Pharmacogenetics Of Cancer Therapy: Breakthroughs From Beyond?

Clinical studies on new anticancer drugs during the past 5 decades in China

Precision Medicine in Oncology: In Vitro Drug Sensitivity and Resistance Test (DSRT) for Selection of Personalized Anticancer Therapy

Searching Synergistic Dose Combinations for Anticancer Drugs

The advancements and prospective developments in anti-tumor targeted therapy

Clinical Evaluation on Platinum Anticancer Drugs

Tumor angiogenesis and anti-angiogenic therapy

Exploring treatment options in cancer: Tumor treatment strategies

Statistical considerations in long-term efficacy evaluation of anti-cancer therapies